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Abstract
The functionality of chromatin is tightly regulated by post-transla-
tional modifications that modulate transcriptional output from
target loci. Among the post-translational modifications of chro-
matin, reversible e-lysine acetylation of histone proteins is promi-
nent at transcriptionally active genes. Lysine acetylation is
catalyzed by lysine acetyltransferases (KATs), which utilize the
central cellular metabolite acetyl-CoA as their substrate. Among the
KATs that mediate lysine acetylation, males absent on the first
(MOF/KAT8) is particularly notable for its ability to acetylate histone
4 lysine 16 (H4K16ac), a modification that decompacts chromatin
structure. MOF and its non-specific lethal (NSL) complex members
have been shown to localize to gene promoters and enhancers in
the nucleus, as well as to microtubules andmitochondria to regulate
key cellular processes. Highlighting their importance, mutations or
deregulation of NSL complex members has been reported in both
human neurodevelopmental disorders and cancer. Based on insight
gained from studies in human, mouse, and Drosophilamodel systems,
this review discusses the role of NSL-mediated lysine acetylation in a
myriad of cellular functions in both health and disease. Through these
studies, the importance of the NSL complex in regulating core tran-
scriptional and signaling networks required for normal development
and cellular homeostasis is beginning to emerge.
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Introduction
Each human cell contains around 2 m of DNA, which must be pack-
aged into a single nucleus that on average is 6 lm in diameter. The
cell achieves this feat by organizing and packaging DNAwith the help
of histone proteins, which together make up chromatin. The
fundamental unit of chromatin is the nucleosome, which contains
approximately 146 bp of double-stranded DNA wrapped around a
histone octamer, composed of two of each histones H2A, H2B, H3,
and H4 [1]. Together, interconnected nucleosomes give chromatin a
“beads-on-a-string” appearance. Rather than being homogenously
distributed in the nucleus, chromatin is segregated into functional
domains that closely regulate the transcriptional activity of the asso-
ciated DNA [2]. Chromatin structure is dynamic, and changes in chro-
matin are associated with cell fate specification during development
[3–5] and maintenance of cellular homeostasis in the face of cellular
stresses [6,7].
Chromatin structure is regulated and modified by a combination
of post-translational modifications that are widespread on DNA and
histones. Over 130 post-translational modifications of histone
proteins have been described to date. These span acetylation,
methylation, ubiquitination, and phosphorylation among others [8].
Unique combinations of histone post-translational modifications
have been proposed to constitute the “histone code” [9,10], which
signals the functionality of the associated region of chromatin. Post-
translational modifications of chromatin can affect the function of
chromatin in at least three ways:
1 Modifying the interaction between DNA and histones [11].
2 Modulating interactions between neighboring histones [12,13],
and thereby local chromatin structure.
3 Forming docking sites for the recruitment of chromatin-modi-
fying complexes [14].
The post-translational modifications of DNA and histones are laid
down by multi-subunit chromatin-modifying complexes, which are
recruited and subsequently act at specific regions of chromatin.
Highlighting their importance, mutations in members of chromatin-
modifying complexes typically result in human developmental
disorders or cancer [15,16].
Among the range of post-translational modifications, reversible
e–lysine acetylation is particularly prominent within cells [17].
Histones associated with transcriptionally active chromatin are
widely decorated with acetylated lysines [18]. Furthermore, over
2,000 cellular proteins have been identified by mass spectrometry
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analysis to possess at least one acetylated e–lysine residue [17].
Besides histones, mitochondrial proteins and metabolic enzymes
show high and dynamic levels of lysine acetylation [19]. The acety-
lation reaction utilizes acetyl-CoA, an intermediate metabolite
generated from metabolic pathways such as aerobic glycolysis and
fatty acid oxidation, to catalyze the acetylation reaction [20]. Given
that cellular acetyl-CoA levels correlate with the energy state of the
cell [21], protein acetylation levels link the metabolic status and
epigenetic landscape of cells [22]. While the acetylation reaction can
occur non-enzymatically under certain conditions such as alkaline
pH [23], which is commonly found in the mitochondria, much of
the acetylation in the cytoplasm and nucleus is thought to be enzy-
matically catalyzed. Enzymatic acetylation of lysine residues is
mediated by KATs, which possess an acetyl-CoA binding site and
can transfer the acetyl group from acetyl-CoA to the Ne–residue of
lysines [20]. The opposing deacetylation reaction is undertaken by
KDACs (also known as HDACs) [24].
Acetylation of chromatin and its importance for transcription
have been particularly well studied. Among the acetylation marks
found on chromatin, histone 4 lysine 16 acetylation (H4K16ac) is
particularly notable for its ability to decompact chromatin structure
[12,13]. H4K16ac is catalyzed by the MYST-family KAT MOF (also
known as KAT8) [25], which is conserved from Drosophila to human
[25–30]. The function of MOF has been best characterized in the fruit
fly D. melanogaster, where it upregulates transcription twofold from
the male X-chromosome to mediate sex-based dosage compensation
(for review see [31–33]). MOF undertakes sex-based dosage compen-
sation in D. melanogaster in the context of the male-specific lethal
(MSL) complex. In addition to the MSL complex, MOF has been
found as the catalytic member of the highly conserved non-specific
lethal (NSL) complex [34]. Compared with the MSL complex, func-
tions of the NSL complex remain enigmatic and have only recently
started to be determined. The NSL complex appears to be wide-
spread within cells, acts broadly, and controls pathways that are crit-
ical for organismal development and cellular homeostasis. This
review will focus on the functions of the NSL complex in transcrip-
tion, its role in the mitochondria and in cell division, as well as the
importance of the NSL proteins in human disease.
Two independent MOF complexes—MSL and NSL
MOF forms the catalytic core of two mutually exclusive complexes
that are conserved from Drosophila to mammals (Fig 1A). MOF was
first established as part of the MSL complex over two decades ago.
Seminal studies in D. melanogaster showed that the MSL complex is
required for the twofold upregulation of H4K16ac and gene tran-
scription from the single male X-chromosome [25,26,28]. This func-
tion of the MSL complex is necessary to balance the gene expression
from a single male X-chromosome to expression from two X-chro-
mosomes in females. While the sex-based dosage compensation
system in mammals is distinct from Drosophila, the MSL complex
has recently been implicated in regulating X-chromosome inactiva-
tion during differentiation of female mouse ESCs [35]. In contrast to
Drosophila, one of the two X-chromosomes in females is inactivated
to balance gene dosage between males and females in mammals. In
mouse ESCs, the MOF-MSL complex binds to the Tsix/Xist locus
[35], which encodes for the Tsix and Xist long non-coding RNAs
that are essential for X-chromosome inactivation. In the absence of
Msl1 or Msl2, Tsix levels are reduced, Xist shows a concomitant
increase in expression, and chaotic X-chromosome inactivation is
observed in differentiating ESCs [35]. The importance of the MSL
complex in mediating transcriptional regulation seems to extend
beyond sex-based dosage compensation. Recent work has estab-
lished that the MSL complex drives H4K16ac and transcription of
highly conserved developmental genes in D. melanogaster and
mouse [36]. Consistently, loss of just one allele of MSL3 leads to
human developmental disorders typified by intellectual disability
Glossary
ANKRD2 ankyrin repeat domain 2
ARL17A ADP ribosylation factor like GTPase 17A
BAH bromo adjacent homology
bp base pair
C. elegans Caenorhabditis elegans (nematode)
ChIP chromatin immunoprecipitation
D. melanogaster Drosophila melanogaster (fruit fly)
D. rerio Danio rerio (zebrafish)
EHMT2 euchromatic histone lysine N-methyltransferase 2
ESC embryonic stem cells
GFAP glial fibrillary acidic protein
HAT histone acetyltransferase
HCF1 host cell factor 1
HDAC histone deacetylase
Hox homeobox
KANSL KAT8-associated non-specific lethal
KAT lysine acetyltransferase
KAT8 lysine acetyltransferase 8; also known as MOF
KDAC lysine deacetylase; also known as HDAC
KdV Koolen de-Vries
MCRS microspherule protein 1
MBT malignant brain tumor protein
MBD-R2 methyl-CpG-binding domain protein R2
MEFs mouse embryonic fibroblasts
MLL mixed lineage leukemia
MOF males absent on the first
MOZ monocytic leukemia zinc finger protein; also known
as KAT6A
MSL male-specific lethal
MYST MOZ, YBF2, SAS2, and TIP60
NPC neural progenitor cell
NSCLC non-small-cell lung carcinoma
NSL non-specific lethal
NUP98 nucleoporin 98
NuRD nucleosome remodeling and deacetylase





PHF20 plant homeodomain finger protein 20
POU5FI POU class 5 homeobox 1
RBBP5 retinoblastoma-binding protein 5
Rheb Ras homolog enriched in brain
RUNX2 Runt-related transcription factor 2
SET Su(var)3-9, Enhancer-of-zeste and Trithorax
TET Ten-eleven translocation
TOP1 DNA topoisomerase 1
TPX2 targeting protein for Xklp2
TUBB3 tubulin beta-3 chain
WDR5 WD Repeat containing domain 5
YEATS Yaf9 ENL AF9 Taf14 Sas5
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and developmental delay [37]. While the recruitment mechanisms
for the MSL complex to the D. melanogaster male X-chromosome
are well studied, future studies are needed to determine how the
MOF-MSL complex is recruited to developmentally important genes
on autosomes. The recruitment mechanism of the mammalian MSL
complex is likely to be unique, as the non-coding roX RNAs that

















































































































































































































































































ª 2019 The Authors EMBO reports 20: e47630 | 2019 3 of 15
Bilal N Sheikh et al EMBO reports
recruit the Drosophila MSL complex to the male X-chromosome are
not found in the mammalian MSL complex [38].
The first indications that MOF could interact with additional
proteins beyond the MSL complex date back to 2005 [28,39]. In 2006,
through systematic purifications and mass spectrometry analyses in
D. melanogaster larvae, SL2 cells, and human HeLa cells, Akhtar and
co-workers identified the full complement of NSL complex members
(Table 1) [34], which was also later independently confirmed by
Conaway and colleagues [40]. The non-specific lethal (NSL) complex
got its name due to the phenotypes of NSL-knockout D. melanogaster
flies. In contrast to depletion of the MSL complex members, which
induces stronger phenotypes in males due to dosage compensation
defects, depletion of the NSL complex members adversely affected
the survival of both male and female flies [34].
Constituents of the NSL complex
The NSL complex is highly conserved, and NSL orthologs have been
identified in a range of organisms including C. elegans [41, preprint:
42] and D. rerio (Fig 1B). There are four core members of the NSL
complex, KANSL1 (also referred to as MSL1v1 [28,39,43]), KANSL2,
KANSL3, and PHF20, which have only been identified as part of the
NSL complex to date [40] (Fig 1C). In contrast, other members of
the NSL complex are shared with other chromatin-modifying
complexes (Fig 1C).
Recent biochemical and structural studies have started to shed
light on how the NSL complex is organized. Both in D. melanogaster
and humans, KANSL1 is unstructured and thought to act as the
major scaffolding protein within the NSL complex [44] (Fig 2A and
B). KANSL1 binds to MOF via its PEHE domain, while interacting
with PHF20 and MCRS1 via its N-terminus (Fig 2A–C). Reminiscent
of MSL1 in the MSL complex, the interaction of MOF with KANSL1
is required to potentiate the catalytic activity of the NSL complex
toward H4K16 and p53-K120, at least in extracellular acetylation
assays [40,43]. Structural work has demonstrated that arginine 592
in human KANSL1 and arginine 721 in D. melanogaster NSL1 medi-
ate their interaction with WDR5/WDR [44]. Substitution of just this
one arginine to an alanine is sufficient to hinder the KANSL1-WDR5
interaction. While KANSL1 interacts with one side of WDR5,
KANSL2 binds to the opposing side via the L411 and V413 residues.
Interestingly, the interaction of KANSL1 and KANSL2 with WDR5 is
reminiscent of the interaction of WDR5 with MLL and RbBP5,
suggesting that the WDR5 subunits in the NSL and MLL complexes
are distinct. The structural analysis thus provides the molecular
basis of how WDR5 engages in mutually exclusive interactions with
MLL and KANSL1, thus leading to two independent and distinct
MLL and NSL complexes that share WDR5. Since both complexes
are promoter-bound, an interplay between MLL and NSL complexes
will be an interesting avenue to explore.
Collaboration between NSL complex members is important for
mediating transcriptional activation. The NSL complex member
OGT O-GlcNAcylates both KANSL3 [45] and HCF1 [46] in immortal-
ized human cells. It has been proposed that OGT-mediated O-
GlcNAcylation of KANSL3 is required for the stability of KANSL3
within the NSL complex and the subsequent catalytic activity of the
complex [45]. Consistently, in NSL3-DNA-GAL4 tethered luciferase
assays, knockdown of Drosophila mcrs2, nsl1, or mof leads to a
◀ Figure 1. Characteristics of NSL complex proteins.(A) The two MOF-containing complexes—the NSL and MSL complexes. The NSL and MSL complex components in the two best studied models, D. melanogaster and human,
are depicted. (B) Conservation of the NSL complex through evolution. The heatmap indicates the level of amino acid similarity in the conserved domains of NSL complex
members. The percentages written over the heatmap indicate the precise amino acid identity in the conserved domains, with the percentage similarity is provided in the
parenthesis. The human NSL protein information was extracted from the NCBI protein database followed by blast of the whole protein sequence to determine the identity of
NSL complex orthologs and amino acid conservation. (C) Core versus shared members of the NSL complex. MOF, the catalytic subunit of the NSL complex, is also found in the
MSL complex [40]. OGT also interacts with the TET enzymes TET1-3 that modify the DNA 5-methyl-cytosine base to 5-hydroxymethyl-cytosine [104–107], as well as the MLL/
SET complexes [108]. In addition to the NSL complex, WDR5 also associates with the MLL trithorax [109] and the MOZ acetyltransferase [110] complexes. HCF1 is shared with
the MLL trithorax complex [108,109,111], while MCRS1 co-immunoprecipitates both NSL and INO80 complex members [40]. In contrast, KANSL1, KANSL2, KANSL3 and PHF20
have only been identified as part of the NSL complex to date.
Table 1. NSL complex members across species.
Human Mouse Zebrafish Fly Worm A. thaliana
MOF (KAT8) MOF (KAT8) kat8 MOF MYS-2 HAM1a
KANSL1 KANSL1 kansl1 NSL1 – –
KANSL2 KANSL2 kansl2 NSL2 (DGT1) SUMV-1 INO80 complex subunit D-likea
KANSL3 KANSL3 kansl3 NSL3 (RCD1) SUMV-2 a/b hydrolase superfamily proteina
PHF20 PHF20 phf20b MBD-R2 – –
MCRS1 MCRS1 mcrs1 MCRS2 (RCD5) MCRS-1 FHA domain containing proteina
WDR5 WDR5 wdr5 WDS WDR-5.1 Transducina
OGT OGT ogt SXCa OGT-1 TPR-like superfamily proteina
HCF1 HCF1 hcf1 HCFa HCF-1 Galactose oxidase/kelch repeat superfamily proteina
Human—Homo sapiens; Mouse—Mus musculus; Zebrafish—Danio rerio; Fly—Drosophila melanogaster; worm—Caenorhabditis elegans; A. thaliana—Arabidopsis
thaliana.
aThese orthologs have been identified through sequence conservation. Whether they are part of the NSL complex remains to be determined.
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reduction in NSL3-mediated luciferase activity [47]. In the context
of the human SET1/COMPASS complex, OGT-mediated O-GlcNAcy-
lation of HCF1 is required for complex stability and methyltrans-
ferase activity of SET1/COMPASS at H3K4 [46]. Whether OGT also
O-GlcNAcylates HCF1 in the context of the NSL complex and how
this may affect NSL complex activity remains to be determined.
In addition to the collaboration within the NSL complex, there
also appears to be a recruitment hierarchy. Depletion of mof in
Drosophila S2 cells does not adversely affect the stability of other
complex members [47]. In contrast, mcrs2, nsl1, or nsl3 RNAi leads
to reduced protein levels of NSL complex partners, suggesting that
recruitment into the NSL complex is important for the stability of
NSL proteins. Similarly, depletion of mcrs2 in Drosophila leads to
reduced binding of MOF, NSL1, and MBD-R2 at chromatin [47].
Furthermore, disruption of the NSL1-WDS interaction results in
lower levels of NSL1 and MBD-R2 at NSL target genes [44]. While
more work is required to determine the precise order of NSL protein
recruitment to chromatin, these data suggest that incorporation of
NSL proteins into the NSL complex is important for their stability.
In addition, it is likely that MOF is one of the last components to be
recruited into the NSL complex, as MOF depletion does not
adversely affect other complex members. It is thus tempting to spec-
ulate that both NSL and MSL complexes can form on chromatin and
MOF is preferably recruited to one of the two complexes depending
on currently unidentified factors. In support of this hypothesis,
“free” MOF that is independent of both the MSL and NSL complexes
has been reported in mouse ESCs [48], as well as in biochemical
assays undertaken in 293T cells [43]. Whether MOF has any activity
in vivo outside of the NSL and MSL complexes is unknown.
However, given that MSL1 and KANSL1 stimulate the catalytic
activity of MOF [43], it is unlikely that “free” MOF possesses signifi-
cant catalytic activity in cells. Despite the insights provided by the
studies discussed here, precisely how the NSL complex members
come together to form a stable complex and are targeted to chro-
matin remains to be established. Furthermore, factors that promote
MOF recruitment into the NSL versus MSL complex remain to be
identified.
NSL complex at chromatin
Consistent with the role of MOF in mediating H4K16 acetylation at
chromatin, the NSL complex is enriched in the nucleus. ChIP of NSL
complex members in D. melanogaster followed by next-generation
sequencing found NSL complex members including NSL1, NSL3,
MCRS2, and MBD-R2 to localize to promoters of over 4,000 genes
[47,49]. Analysis of NSL-bound genes in D. melanogaster revealed
that NSL proteins are enriched at gene promoters of constitutively
active housekeeping genes (Fig 3A, left panel) [47,49,50]. These
NSL target promoters are highly enriched in histone modifications
classically associated with transcriptionally active promoters includ-
ing H4K16ac, H3K9ac, H3K4me2, and H3K4me3 [49].
More recently, genome-wide ChIP profiles have also been gener-
ated for the mouse NSL complex members KANSL1 [48], KANSL3
[35], MCRS1 [35], and MOF [35,48,51] in ESCs and NPCs. Like
Drosophila, mammalian MOF-NSL complex members tend to local-
ize to promoters of transcriptionally active genes [35,48,51]. While
a significant proportion of NSL-bound genes in ESCs are also
housekeeping, the mammalian NSLs are also present at some
developmentally important genes and enhancers. Indeed, KANSL3
[35] and MOF [52] bind to a subset of active enhancer elements in
mouse ESCs and their binding is lost in more differentiated cell
types. While the significance of MOF and KANSL3 binding to
enhancers in ESCs remains to be determined, MOF appears to be
important for maintenance of the Nanog-mediated pluripotency
network in mouse ESCs [51]. This function of MOF is likely to be
mediated in the context of the NSL complex, as depletion of Kansl3
but not Msl1 or Msl2 leads to the loss of alkaline phosphatase
staining and reduced expression of the pluripotency factors Nanog,
REX1, and ESRRB in mouse ESCs [35]. Consistently, ESC lines
could not be established from blastocysts lacking Mof [27] or Phf20
[53], while fibroblasts lacking Phf20 could not activate pluripotency
genes after induction of pluripotency via the Yamanaka factors
[53]. These cell culture experiments suggest an important role for
the NSL complex during the developmental period. Consistently,
Mof-knockout mice display early embryonic lethality at around the
blastocyst stage [27,30], while Phf20-knockout mice are highly
runted and the majority die around birth [54]. However, the in vivo
role of other NSL complex members during development remains
to be established via mouse models, especially in a tissue- or cell-
specific manner.
Precisely what mediates the requirement for the NSL complex for
transcription remains an open question. It is plausible that the NSL
complex binds and primes a subset of genes for activation upon a
certain stimulus. Underpinning this hypothesis, MOF has recently
been suggested to be important for stress response in kidney podo-
cytes in the context of the NSL complex [55]. Conditional deletion
of Mof in terminally differentiated podocytes, key components of
the kidney filtration barrier, had no adverse effect at steady state.
However, when conditional Mof-knockout mice were exposed to a
mild stressor, they were unable to respond leading to the break-
down of glomerulus structure and kidney failure [55]. Comparison
of gene expression changes and ChIP profiles suggested that MOF
induced the response to cellular stress in podocytes in the context of
the NSL complex. In the future, it would be of interest to indepen-
dently verify the importance of NSL complex members in stress
responses.
Given that the main function of MOF is acetylation of H4K16,
studies have looked at the ability of MOF to acetylate H4K16 as part
of the NSL complex. While extracellular biochemical studies with
◀ Figure 2. Domain organization and structure of NSL complex members.(A) Schematic representation of protein domain organization of human (hu) and D. melanogaster (dm) NSL complex members based on NCBI annotations. Numbers on either
side of the respective domain represent its start and end amino acid position. The horizontal bars denote the binding region of the protein indicated above it. The red stars
indicate the protein domains of the structures demonstrated in panels (C–G). (B) Summary model of human NSL complex based on structural and protein interaction studies
[44]. (C) Ribbon representation of the crystal structure of a KANSL1, WDR5, and KANSL2 sub-complex (PDBID 4CY2) [44]; (D) NMR structure of the chromobarrel domain of
D. melanogaster MOF (PDBID 2BUD) [112]; (E) X-ray diffraction structure of the HAT domain of human MOF (PDBID 2PQ8); (F) X-ray structure of the Tudor domain of PHF20
(PDBID 3QII) [113]; (G) PHD domain of PHF20 (PDBID 5TAB) [57].
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selected complex members added to MOF have shown NSL complex
activity toward H4K16ac [40], studies undertaken in cells and
organisms have suggested that the NSL complex maintains only a
small proportion of global H4K16ac. While knockdown of Mof or
Msl1 in mouse ESCs leads to a global reduction in H4K16ac, no
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knockdown of Kansl1 or Kansl3 [35,48]. Similarly, while chromatin
binding of NSL1 and MBD-R2 in D. melanogaster shows an overlap
with H4K16ac, depletion of mcrs2 in SL2 cells does not lead to a
bulk reduction in H4K16ac levels [47]. Quantitative mass spectro-
metric analysis of histones has also confirmed that msl1 and mof
but not nsl1 depletion lead to reduced bulk H4K16ac in Drosophila
S2 cells [56]. Together, these findings suggest that MOF is more
likely to mediate global H4K16ac in the context of the MSL complex.
Nevertheless, it is possible that NSL complex depletion leads to a
more localized reduction in H4K16ac levels around NSL-bound
promoters. Indeed, Klein and co-workers found reduced H4K16ac at
PHF20 target genes upon PHF20 knockdown in H1792 lung adeno-
carcinoma cells [57]. In this context, it is also interesting to note that
depletion of NSL complex members is associated with reduced
levels of RNA polymerase II, TBP, and TFIIB at NSL target promot-
ers in flies [49], suggesting that the NSL complex may also be
involved in the recruitment of the transcriptional machinery. In
D. melanogaster, NSL1 binding shows a strong overlap with
members of other core chromatin complexes including the trithorax,
chromator, and NURF complexes [50,58]. Thus, it is tempting to
speculate that like other KATs such as p300 and CBP [59], the MOF-
NSL complex may also directly acetylate and modulate the activity
of chromatin regulators or the transcriptional machinery. Consis-
tently, Drosophila MCRS2 is perpetrated to directly interact with and
recruit the RNA polymerase II complex to target genes [60]. In the
future, it will be important to determine the precise extent of NSL
activity toward H4K16 in vivo as well as the H4K16-independent
targets of the NSL complex in transcription.
Cooperation between the NSL complex and other
chromatin complexes
Individual chromatin complexes do not function on their own, but
rather cooperate with other nuclear proteins to fine-tune transcrip-
tional programs (Fig 3A, right panel). There are two main mecha-
nisms through which chromatin complexes achieve this
collaboration. Members of chromatin-modifying complexes possess
“reader” domains that detect and are recruited to specific post-trans-
lational modifications. For instance, bromodomains and YEATS
domains show affinity for acetylated lysines while chromodomains,
BAH domains, Tudor domains, and MBT domains are recruited to
methylated lysines [61–65]. In addition, chromatin complexes can
physically interact with other chromatin modules or transcription
factors. The NSL complex uses both of these strategies to collaborate
with other nuclear proteins to regulate transcription.
The NSL complex consists of a number of “reader” modules
(Fig 2A). These modules are particularly enriched in PHF20, which
contains a PHD domain as well as two Tudor domains (Fig 2A, F
and G). The PHD domain of PHF20 shows specificity for H3K4me2
[57], a mark enriched at active promoters and laid down by the
MLL/COMPASS family of proteins. Structural and biochemical stud-
ies have shown that the E662 residue of PHF20 is critical for the
detection of and affinity to H3K4me2 (Fig 2G). Knockdown of
PHF20 in human lung adenocarcinoma cells leads to reduced cell
proliferation as well as diminished H4K16ac [57], suggesting that
the MOF-NSL complex is recruited by PHF20 to H3K4me2-positive
promoters where it catalyzes H4K16ac. There is also some evidence
that the NSL complex can reciprocally promote H3K4me2. At the
ANKRD2 promoter, depletion of KANSL1 or MOF results in reduced
H3K4me2, while depletion of the MLL complex member RBBP5 only
diminishes H3K4me2 and not H4K16ac [66]. Thus, there is accumu-
lating evidence that the NSL and MLL complexes not only share
components such as WDR5 and HCF1, but they can also corporate
at the level of chromatin. However, more work is needed to system-
atically determine precisely how the crosstalk between the NSL and
MLL/COMPASS complexes takes place.
In addition to the PHD domain, PHF20 also possesses two Tudor
domains, which are thought to recruit the NSL complex to estrogen
receptor alpha (ERa) target genes. Upon activation, ERa is dimethy-
lated by EHMT2 (also known as G9a) at K235 and monomethylated
at K303 [67]. The ERa-K235me2 modification is recognized by the
second Tudor domain of PHF20 (Fig 2F) and is required for the
deposition of H4K16ac at ERa/PHF20 target loci [67]. Similarly, the
second Tudor domain of PHF20 is also able to recognize p53 methy-
lated at K370 and K382 [68]. The association of PHF20 with methy-
lated p53 is thought to protect p53 from ubiquitin-mediated
degradation and thereby stabilize p53 in response to stress [68].
Consistently, depletion of PHF20 leads to reduced levels of p53 and
attenuated activation of p53 target genes. Thus, the NSL complex is
able to recognize post-translational modifications via PHF20 to inte-
grate cell signals with transcriptional output.
The NSL complex can also interact with a number of nuclear
proteins. Two independent studies have shown that NSL complex
members can physically interact with components of the nuclear
pore. The nuclear pore mediates the transport of molecules in and
out of the nucleus, and more recent studies have also implicated the
nuclear pore complex in regulating chromatin structure [69].
◀ Figure 3. Multiple facets of the NSL complex.(A) The NSL complex regulates nuclear gene transcription. In D. melanogaster, the NSL complex localizes to gene promoters andmaintains the positioning of the +1 nucleosome
(middle panel). In addition, the NSL complex acetylates H4K16, which is enriched at promoters as well as gene bodies of transcriptionally active genes (left panel). A similar
chromatin-binding pattern is observed in mammalian cells, whereby MOF, KANSL3, andMCRS1 localize to active gene promoters and to a lesser extent, to enhancers in mouse
ESCs. The plot on the left side of panel (A) was generated by apportioning all NSL-bound regions in ChIP-seq data from male mouse ES cells [35] into different chromatin
states [114]. To mediate transcriptional control, the MOF-NSL complex interacts with other chromatin complexes and transcription factors, allowing for crosstalk and
collaboration between different signaling pathways and chromatin regulators (right panel). (B) Besides histones, MOF acetylates non-histone proteins such as p53 [115]. This
encourages investigation of MOF partner proteins and MOF targets outside of chromatin. Moreover, MOF has been implicated in catalyzing other –acyl chains such as
crotonylation and propionylation [116,117]. However, the precise contribution of MOF and its NSL complex members to non-acetyl acylations needs further investigation. (C)
KANSL1, KANSL3, and MCRS1 localize to microtubules during mitosis and are required for the progression of cells through cell division. (D) The NSL complex members MOF,
KANSL1, and KANSL3 localize to the mitochondria. This finding has opened up a new horizon for the study of the predominantly chromatin-associated NSL complex in the
regulation of mitochondrial biology. (E) MOF, KANSL1, KANSL2, and MCRS1 are dysregulated in various types of cancer, and the misregulation of NSL complex members drives
tumor pathology and aggressiveness. (F) The MOF-NSL complex is implicated in multi-organellar stress responses by maintaining key transcriptional networks such as
autophagy andDNA repair. (G) Heterozygous deletion or pointmutations in human KANSL1 (adapted frompatient entries onDECIPHERGRCh37) cause the KdV syndrome,which
is typified by developmental abnormalities and intellectual disability. How the NSL complex regulates development and brain function, however, is an outstanding question.
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Capelson and co-workers undertook an unbiased comparison of the
nuclear pore component NUP98 ChIP profile to other publically
available chromatin datasets and found NUP98 to most closely over-
lap with NSL component MBD-R2 in Drosophila S2 cells [70].
Further interrogation of this relationship revealed that MBD-R2
could immunoprecipitate NUP98. Similarly, another nuclear pore
component, NUP153, was found to interact with NSL1 in an unbi-
ased mass spectrometry analysis [34]. While the complete signifi-
cance of these interactions remains to be established, depletion of
NSL complex member MBD-R2 via RNAi leads to reduced recruit-
ment of NUP98 to chromatin [70], suggesting that the NSL complex
may be important for the chromatin targeting of nuclear pore
components. This is consistent with the observation that the nuclear
pore complex is important for chromatin organization [69].
In addition to components of the nuclear pore complex, ChIP
profiles display a strong overlap of NSL1 with components of the
D. melanogaster trithorax and NURF complexes [50]. Recent work
has identified that NSL complex components interact directly with
the NURF complex members NURF301, NURF38, and p55 [58].
NSL3 was shown to bind TATA-less housekeeping promoters in a
DNA sequence-dependent manner and the NSL complex was subse-
quently able to recruit the NURF complex [58]. Consistently, deple-
tion of NSL complex members by RNAi leads to disruption of the
nucleosomal organization around the transcription start sites of
NSL-bound genes and increased transcriptional noise [58]. Thus,
NSL-dependent recruitment of the NURF complex appears to be
important for faithful transcription from NSL target housekeeping
genes, at least in Drosophila. Whether this interaction is conserved
in mammalian cells remains to be ascertained.
While the NSL complex can directly bind to DNA at least in
Drosophila, reports in the mammalian system have perpetrated NSL
complex members to interact with DNA-binding transcription
factors, thus providing a potential mechanism for NSL recruitment
to chromatin. During osteoblast differentiation, PHF20 upregulates
the transcription of RUNX2, an important transcription factor in the
osteogenic lineage [71]. Furthermore, overexpression studies
showed that PHF20 and RUNX2 physically interact and synergisti-
cally promote transcription at target promoters [71]. Similarly, upon
activation of c-Jun in 293T cells, activated but not inactive c-Jun
was able to associate with KANSL2 and KANSL3 but not MSL1 or
MSL2 [72]. The NSL complex was required for mediating the
removal of the inhibitory NuRD complex at c-Jun target loci,
increasing H4K16ac and thus inducing the expression of c-Jun target
genes [72]. Thus, it is starting to become apparent that the NSL
complex binds to promoters of genes and coordinates the activation
of transcription together with a number of transcription factors and
chromatin remodelers. Since every cell type has unique require-
ments for the activation of specific genes, it will be important to
determine precisely how the NSL complex is recruited in different
cell types, whether there is a conserved recruitment mechanism, or
whether there are specific binding partners of NSLs in particular cell
types.
The NSL complex beyond chromatin
While the NSL complex is highly enriched at chromatin, recent stud-
ies have shed light on the dynamic sub-cellular localization and
function of NSLs, thereby pointing toward a role beyond nuclear
gene expression. Members of the NSL complex, KANSL1, KANSL3,
and MCRS1 relocate from nuclear chromatin to the minus-ends of
microtubules when cells leave interphase and enter mitosis [73].
Using the Xenopus egg extract system, in which transcription is fully
inhibited, Meunier and co-workers showed that KANSL1, KANSL3,
and MCRS1 stabilize microtubules and interact with the essential
spindle assembly factor TPX2 in a transcription-independent
manner (Fig 3C). The interaction between the NSL complex proteins
and TPX2 promotes microtubule assembly and stabilization of chro-
mosomal microtubules. Consistently, knockdown of KANSL1,
KANSL3, or MCRS1 in HeLa cells results in dramatic mitotic defects
including mitotic delay, chromosome scattering, multipolar spin-
dles, and reduced microtubule stability [73]. While this study high-
lights a key role for NSL complex members during mitosis, future
studies are required to determine whether this mechanism is
conserved in non-cancerous cells and in vivo.
In addition to microtubules, the presence of MOF, KANSL1, and
KANSL3 has also been reported in mitochondria [74]. MOF and
KANSL3 localize to the D-loop of mitochondrial DNA and are
required to maintain transcription of the mitochondrial genome, at
least in the context of HeLa cells (Fig 3D). As a consequence, deple-
tion of MOF or KANSL1 in HeLa cells results in impaired mitochon-
drial respiration [74]. The importance of mitochondrial localization
of MOF was revealed through rescue studies. Mitochondrial respira-
tion of MOF-depleted cells could be rescued by the reintroduction of
a mitochondrially targeted wild type but not catalytic dead MOF,
possibly decoupling the nuclear and mitochondrial functions of the
MOF-NSL complex. The role of MOF in the mitochondria is however
only beginning to be understood, and several aspects still need to be
thoroughly investigated. For instance, since NSL proteins contain
both nuclear and mitochondrial targeting signals, it is important to
determine the triggers that dictate mitochondrial versus nuclear
recruitment of NSL complex members. Furthermore, the knowledge
of how MOF depletion from one cellular compartment affects the
function of the other organelle would unveil whether and how MOF
can mediate cross-organellar communication to maintain cellular
homeostasis. Despite these outstanding questions, the role of MOF
in regulating aspects of metabolism is likely to be important. Mouse
models lacking Mof in cardiomyocytes display swollen and degener-
ated mitochondria, reduced cardiac function, and eventually die due
to cardiomyopathy [74]. Furthermore, duplications in exons 1–3 of
the human KANSL1 gene are associated with a greater risk of
congenital heart defects [75]. It remains to be determined, however,
whether the nuclear or mitochondrial function of the MOF-NSL
complex is more important for cardiac development and function.
In addition to regulating metabolism and cell growth, members
of the NSL complex have also been implicated in autophagy.
mTORC1 is a central regulator of cell growth versus catabolism.
mTORC1 promotes cellular growth when nutrients are plentiful
while inhibition of mTORC1 is associated with autophagy [76].
MCRS1 is required for amino acid-dependent mTORC1 activation in
HEK293T and HCT-116 cells. GTP-bound Rheb directly stimulates
the autophagy signal integrator mTORC1. In the presence of amino
acids, MCRS1 bridges the interaction between Rheb-GTP and
mTORC1 at the site of late endosomes/lysosomes, resulting in
mTORC1 stimulation. In the absence of amino acids, the MCRS1-
Rheb interaction is lost and binding between Rheb and the GTPase
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TSC2 is favored instead. Consistently, loss of MCRS1 mimics amino
acid starvation in both mouse and human cells [77]. Thus, it
appears that MCRS1 and MOF play distinct roles in autophagy, as
MOF-mediated H4K16ac is downregulated following amino acid
starvation in MEFs [78]. While it is currently difficult to reconcile
the differences between MCRS1 and MOF function in autophagy, it
is plausible that the role of MCRS1 in autophagy is distinct from its
function in the NSL complex as it also associates with the INO80
complex.
While the studies discussed here are starting to reveal impor-
tant functions of NSL complex members beyond the level of chro-
matin, there are still a number of outstanding questions that
require attention (see Box 1: In need of answers). For instance, do
NSL complex members localize to other organelles beyond the
nucleus and mitochondria? Do NSL complex members have
unique non-chromatin functions outside of the core NSL complex?
What are the precise targets of NSL complex activity in various
organelles and the cytoplasm? Given the widespread nature of
lysine acetylation [17], and the importance of NSL function in
cells at a multi-organellar level, it is likely that the NSL complex
has widespread targets. The identification of the non-histone
targets will help shed light on the extent of NSL function within
cells in the context of transcription as well as other novel regula-
tory mechanisms.
NSL complex in human health and disease
Given the critical role of the NSL complex in maintaining cellular
homeostasis, mutations or deregulation of NSL proteins leads to
severe human disease. Heterozygous mutations in KANSL1 have
been found in around 1:16,000 live births [79] and underlie the
KdV syndrome [80,81], a severe developmental disorder typified
by developmental delay, intellectual disability, facial dysmor-
phisms, low birthweight, and a range of comorbidities [79].
Furthermore, a screen for genetic variants in severe intellectual
disability identified mosaic point mutations in KANSL2, which are
predicted to induce splicing defects in KANSL2 transcripts [82].
The precise frequency of disease-causing KANSL2 variants
remains to be determined. In comparison, given the high preva-
lence of KdV syndrome, KdV patients have been well character-
ized. KdV patients typically present with a low IQ, but display
friendly behavior [79]. Recent MRI studies revealed that KdV
patients generally display morphological defects including
hippocampal malformations, corpus callosum dysgenesis, and
dilated ventricles [83]. Given the severity and prevalence of the
KdV syndrome, researchers have attempted to model aspects of
KdV in mouse models to determine the underlying molecular
mechanisms. Kansl1+/ mice model most aspects of KdV
patients, including low body weight and reduced performance in
memory and learning tests such as novel object recognition
assays and fear conditioning paradigms [84]. However, despite
these animal studies and analysis of human patients, the underly-
ing molecular networks leading to defective development and
brain function in KdV patients remain unknown. Given that
KANSL1 haploinsufficiency likely results in reduced levels of
KANSL1 [79] and KANSL1 is required for the full catalytic activ-
ity of MOF within the NSL complex [43], the underlying
molecular defect is likely to involve reduced acetylation levels at
NSL targets and disrupted gene transcription. Transcriptomic stud-
ies on human patient material and in mouse models are required
to determine precisely which gene networks are dysregulated
upon KANSL1 haploinsufficiency.
In addition to developmental disorders, deregulation of NSL
complex members has been reported in malignancies (Fig 3E).
Reduced H4K16ac is strongly associated with a wide range of malig-
nancies [85]. Consistently, independent studies have reported MOF
to be downregulated in a panel of cancer types including breast
cancer [86], ovarian epithelial cancer [87], colorectal carcinoma
[88], gastric cancer [88,89], hepatocellular carcinoma [90], and
medulloblastoma [86]. How the downregulation of MOF and
H4K16ac drives tumorigenesis remains unknown, as paradoxically,
depletion of MOF leads to cell cycle arrest in primary cell culture
systems [55].
In contrast to MOF and H4K16ac, other members of the NSL
complex appear to play a pro-oncogenic role in cancer. MCRS1
upregulation has been reported in colorectal carcinoma [91,92],
glioma [93,94], and NSCLC [93]. In each of these cancers, increased
levels of MCRS1 correlate with cancer aggressiveness and poor
survival. Consistently, knockdown of MCRS1 in colorectal cancer
cells leads to reduced cell proliferation along with lower levels of
cyclin D1 and CKD4 as well as increased p21 expression [91]. Simi-
larly, MCRS1 depletion in glioma cells results in reduced tumori-
genicity both in vitro and in nude mouse models [94]. Reminiscent
of MCRS1, KANSL2 is reportedly upregulated around sevenfold in
glioblastoma samples compared to adjacent normal tissue [95].
KANSL2 was shown to drive the stem cell-like features of glioblas-
toma cells, and knockdown of KANSL2 reduced expression of the
pluripotency factors NANOG and POU5FI, while it increased the
expression of the neural differentiation markers TUBB3 and GFAP
[95]. Consistently, reduced KANSL2 levels result in smaller tumors
after transplantation of KANSL2-depleted glioblastoma cells into
immunodeficient mice.
There is one notable exception to the downregulation of MOF in
cancers. MOF is highly expressed in non-small-cell lung cancer
(NSCLC), and increased expression levels are associated with poor
survival [96]. In contrast, reduced PHF20 levels are reportedly asso-
ciated with poor survival in NSCLC [97]. The underlying reason for
this unique correlation between MOF, PHF20 levels, and NSCLC
progression is unknown, but it will be important to determine, as
NSCLCs account for around 85% of lung cancers and are typically
resistant to chemotherapy.
It is interesting to note that reduced MOF and H4K16ac levels but
increased levels of MCRS1 and KANSL2 are associated with cancer
progression and aggressiveness. While these observations are diffi-
cult to reconcile on a molecular level, it is plausible that reduced
MOF levels in cancer are associated with the activity of the MSL
complex. Consistently, depletion of MSL complex but not NSL
complex members is associated with a global reduction of H4K16ac
in both Drosophila and mammals [35,47,48,56], which is similar to
the observations in cancer cells [85]. In the future, it will be impor-
tant to determine the function of MOF in the context of the MSL
versus NSL complex in driving malignancies. Moreover, further
molecular characterization should reveal important insights into the
functions of the two complexes in driving cancer traits such as self-
renewal, cell proliferation and apoptosis.
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Among NSL complex members driving cancer traits, mutations in
KANSL1 have been reported to promote malignancies. Zhou and co-
workers recently identified a KANSL1-ARL17A fusion transcript in
cancer samples isolated specifically from patients with European
ancestry [98]. KANSL1 and ARL17A are neighboring genes on human
chromosome 17. The authors found that the KANSL1-ARL17A fusion
is inherited within European populations and could predispose carri-
ers to cancer [98]. In addition, KAT6B-KANSL1 translocations have
been identified in a woman with retroperitoneal leiomyoma [99], but
how the KAT6B-KANSL1 translocation drives this cancer remains to
be identified. It is likely that with more widespread use of next-
generation sequencing technologies, novel mutations in NSL complex
members in cancer will be identified. In addition to these mutations,
NSL and MLL complex members have been shown to interact with
leukemogenic translocation proteins NUP98-HOXA9, NUP98-
HOXD13, NUP98-NSD1, NUP-PHF23, and NUP98-TOP1 [100]. These
findings are consistent with work showing that NSL complex
members associate with wild-type nuclear pore complex components
[34,70]. Xu and co-workers found that depletion of Mll1 from NUP98-
HOXA9 driven leukemic cells was sufficient to reduce the number of
leukemic cell growth and increase survival of mice transplanted with
NUP98-HOXA9 transduced hematopoietic progenitor cells [100]. The
significance of the NSL complex interaction with NUP98 fusion
proteins was not determined in this study, and whether the NSL
complex is required for the NUP98 fusion protein-driven leukemic
transcription program remains to be established.
Together, these studies suggest an important role for the MOF-
NSL complex in regulation of neurological functions and carcino-
genesis. Future studies are required to better establish the molecular
mechanism by which the individual NSL complex members orches-
trate neural development and regulate tumor growth, metastasis,
and invasion. Given the variable requirements for NSL complex
members for growth of different cancer types, it will be important to
study NSL proteins in specific cancer subtypes to better understand
their role in cancer.
Conclusions
Since the discovery of the NSL complex just over a decade ago, a
number of studies spanning mouse and Drosophila model systems
as well as human samples have revealed the functional impor-
tance of the NSL complex (Fig 3). At the level of chromatin, the
NSL complex regulates transcriptional networks critical for the
maintenance of cellular homeostasis. Mutations or deregulation of
NSL complex members results in malignancy or developmental
disorders. In addition, the individual complex members are begin-
ning to be biochemically characterized and their catalytic activi-
ties and binding partners are being established. We are now also
starting to appreciate that the NSL complex functions beyond
mere transcriptional regulation. Certain NSL complex members
localize to microtubules as well as to the mitochondria in a
dynamic manner. Whether NSL complex members can also local-
ize to other organelles remains to be determined and will be an
exciting avenue of research to pursue. Furthermore, whether NSL
complex members show dynamic cell type-dependent recruitment
to chromatin or to different organelles remains to be established.
Work utilizing Mof-knockout mouse models [51,55,78,101–103]
indeed suggests that the NSL complex is likely to possess cell type-
specific and cellular context-specific functions, which remain to be
formally tested in NSL model systems. Furthermore, global screens
for MOF-NSL acetylation targets as well as NSL binding partners in
different cell types are required to better understand the extent of
NSL-mediated control in cells (see Box 1: In need of answers).
Overall, it is becoming clear that the NSL complex plays a
central role in controlling transcriptional networks and cell signal-
ing pathways and is deregulated in a range of human disease
(Fig 3). Thus, it is pertinent to better understand the mechanistic
workings of the NSL complex. The field will look toward develop-
ing a better understanding of the myriad of NSL complex functions
as well as the biochemical role of its individual members in the
coming years.
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